Sponsor

TargED Biopharmaceuticals B.V.

The Netherlands Princetonlaan 6, 3584 CB Utrecht, The Netherlands

About the sponsor

TargED Biopharmaceuticals B.V. is involved in clinical research for acute ischemic stroke, with interest in treatment settings where rapid restoration of blood flow and neurological protection are central concerns.

Neurovascular thrombosis
Endovascular thrombectomy
Acute stroke care

The sponsor’s work in this area reflects a focus on cerebrovascular disease and the management of time-sensitive ischemic injury.

About Specializations

TargED Biopharmaceuticals B.V. runs clinical trials in conditions such as Ischaemic stroke, Thrombotic thrombocytopenic purpura, Thrombotic microangiopathy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

2 clinical trials

Ischaemic stroke

Recruiting

Registered drug

A Study of TGD001 in Patients with Acute Ischemic Stroke to Test Safety and Effectiveness

Registered drug

Germany

Participants:18–64 years · 65+ years
Substances:Sodium Chloride Solution 0.9%
Sponsor:TargED Biopharmaceuticals B.V.

Contact Research Centre

Thrombotic thrombocytopenic purpura+1

Not yet recruiting

InvestigationalNo placebo

A study to evaluate the safety and effectiveness of urokinase, catalytic domain, fused with a single-chain antibody against von Willebrand factor in patients with immune-mediated thrombotic thrombocytopenic purpura.